>_ QFI Terminal
Terminal › Stocks › CUPR

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) Stock

Healthcare · Biotechnology · SG
$2.06 +21.89%
Last updated Nov 12, 2026 10:46 UTC

CUPR Key Statistics

Market Cap$44.08M
P/E (TTM)—
P/S (TTM)—
P/B (TTM)-10.05
Revenue (TTM)$0.00
EPS (TTM)—
Dividend Yield—
ROE (TTM)42.42%
Net Margin-3,229.52%
Gross Margin-6.26%
52W High$14.80
52W Low$0.28
Analyst View—
Price Target—
Employees15
Volume58,554

About Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

Cuprina Holdings (Cayman) Limited is a Singapore-based biomedical and biotechnology company dedicated to developing and commercializing innovative products for managing chronic wounds. The company manufactures and distributes medical-grade sterile blowfly larvae bio-dressing products under the MEDIFLY brand, used as a biological debridement tool for chronic wounds. Additionally, Cuprina operates in the health and beauty sectors, offering cosmeceutical products.

CEO: Yong Qi Quek. Company website

CUPR — Frequently Asked Questions

What is the CUPR stock price today?

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) trades at $2.06, up 21.89% on the day, as of Nov 12, 2026 10:46 UTC.

What is Cuprina Holdings (Cayman) Limited Class A Ordinary Shares's market cap?

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares has a market capitalisation of $44.08M, calculated from the live CUPR share price and shares outstanding.

How much revenue does Cuprina Holdings (Cayman) Limited Class A Ordinary Shares make?

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares generated revenue of $0.00 over the trailing twelve months.

What is the 52-week range for CUPR?

CUPR has traded between $0.28 and $14.80 over the past 52 weeks, and the last price is 86.1% below that high.

Is Cuprina Holdings (Cayman) Limited Class A Ordinary Shares profitable?

No. Cuprina Holdings (Cayman) Limited Class A Ordinary Shares is loss-making, with a net margin of -3,229.52% over the trailing twelve months.

What sector is Cuprina Holdings (Cayman) Limited Class A Ordinary Shares in?

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares is classified under the Healthcare sector and the Biotechnology industry, and is domiciled in SG .

Who is the CEO of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares?

Yong Qi Quek is the chief executive of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares, which employs 15 people.

Where can I track CUPR in real time?

QFI Terminal shows CUPR with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See CUPR live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open CUPR in Terminal See plans

Biotechnology stocks

REGN Regeneron Pharmaceuticals, Inc. VRTX Vertex Pharmaceuticals Incorporated ONC BeOne Medicines AG INCY Incyte Corporation ALNY Alnylam Pharmaceuticals, Inc. JAZZ Jazz Pharmaceuticals plc ARGX argenx SE GMAB Genmab A/S NBIX Neurocrine Biosciences, Inc. BMRN BioMarin Pharmaceutical Inc. UTHR United Therapeutics Corporation CDT CDT Equity Inc. MRNA Moderna, Inc. EXEL Exelixis, Inc. BNTX BioNTech SE SRPT Sarepta Therapeutics, Inc. HALO Halozyme Therapeutics, Inc. INSM Insmed Incorporated MDGL Madrigal Pharmaceuticals, Inc. TECH Bio-Techne Corporation ASND Ascendis Pharma A/S CAI Caris Life Sciences, Inc. IONS Ionis Pharmaceuticals, Inc. BBIO BridgeBio Pharma, Inc.

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. CNC Centene Corp. ELV Elevance Health Inc. HUM Humana Inc. JNJ Johnson & Johnson LLY Eli Lilly and Company HCA HCA Healthcare, Inc. MRK Merck & Co., Inc. ABBV AbbVie Inc. PFE Pfizer Inc.